MAPT and Alzheimer disease: The odor identification score displayed no correlation with any AD biomarkers in the CSF for either the group classified as the normal biomarkers and p-Tau accumulation without amyloidogenesis group (Table 5B), or in the normal and SNAP group (Table 5C).